These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 8944320)

  • 1. Similarity of neuronal cell injury and death in AIDS dementia and focal cerebral ischemia: potential treatment with NMDA open-channel blockers and nitric oxide-related species.
    Lipton SA
    Brain Pathol; 1996 Oct; 6(4):507-17. PubMed ID: 8944320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuronal injury associated with HIV-1: approaches to treatment.
    Lipton SA
    Annu Rev Pharmacol Toxicol; 1998; 38():159-77. PubMed ID: 9597152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-related neuronal injury. Potential therapeutic intervention with calcium channel antagonists and NMDA antagonists.
    Lipton SA
    Mol Neurobiol; 1994; 8(2-3):181-96. PubMed ID: 7999315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AIDS-related dementia and calcium homeostasis.
    Lipton SA
    Ann N Y Acad Sci; 1994 Dec; 747():205-24. PubMed ID: 7847672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on current models of HIV-related neuronal injury: platelet-activating factor, arachidonic acid and nitric oxide.
    Lipton SA; Yeh M; Dreyer EB
    Adv Neuroimmunol; 1994; 4(3):181-8. PubMed ID: 7874385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuronal injury associated with HIV-1 and potential treatment with calcium-channel and NMDA antagonists.
    Lipton SA
    Dev Neurosci; 1994; 16(3-4):145-51. PubMed ID: 7705221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-related neurotoxicity.
    Lipton SA
    Brain Pathol; 1991 Apr; 1(3):193-9. PubMed ID: 1669708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of immune activation and cytokine expression in HIV-1-associated neurologic diseases.
    Yoshioka M; Bradley WG; Shapshak P; Nagano I; Stewart RV; Xin KQ; Srivastava AK; Nakamura S
    Adv Neuroimmunol; 1995; 5(3):335-58. PubMed ID: 8748077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a human neuronal cell model for human immunodeficiency virus (HIV)-infected macrophage-induced neurotoxicity: apoptosis induced by HIV type 1 primary isolates and evidence for involvement of the Bcl-2/Bcl-xL-sensitive intrinsic apoptosis pathway.
    Chen W; Sulcove J; Frank I; Jaffer S; Ozdener H; Kolson DL
    J Virol; 2002 Sep; 76(18):9407-19. PubMed ID: 12186923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular and cellular mechanisms of neuronal cell death in HIV dementia.
    Li W; Galey D; Mattson MP; Nath A
    Neurotox Res; 2005 Oct; 8(1-2):119-34. PubMed ID: 16260390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethanol potentiates HIV-1 gp120-induced apoptosis in human neurons via both the death receptor and NMDA receptor pathways.
    Chen W; Tang Z; Fortina P; Patel P; Addya S; Surrey S; Acheampong EA; Mukhtar M; Pomerantz RJ
    Virology; 2005 Mar; 334(1):59-73. PubMed ID: 15749123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathways to neuronal injury and apoptosis in HIV-associated dementia.
    Kaul M; Garden GA; Lipton SA
    Nature; 2001 Apr; 410(6831):988-94. PubMed ID: 11309629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemokines and activated macrophages in HIV gp120-induced neuronal apoptosis.
    Kaul M; Lipton SA
    Proc Natl Acad Sci U S A; 1999 Jul; 96(14):8212-6. PubMed ID: 10393974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The chemical biology of clinically tolerated NMDA receptor antagonists.
    Chen HS; Lipton SA
    J Neurochem; 2006 Jun; 97(6):1611-26. PubMed ID: 16805772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokine-stimulated, but not HIV-infected, human monocyte-derived macrophages produce neurotoxic levels of l -cysteine.
    Yeh MW; Kaul M; Zheng J; Nottet HS; Thylin M; Gendelman HE; Lipton SA
    J Immunol; 2000 Apr; 164(8):4265-70. PubMed ID: 10754324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory mediators leading to protein misfolding and uncompetitive/fast off-rate drug therapy for neurodegenerative disorders.
    Lipton SA; Gu Z; Nakamura T
    Int Rev Neurobiol; 2007; 82():1-27. PubMed ID: 17678953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failures and successes of NMDA receptor antagonists: molecular basis for the use of open-channel blockers like memantine in the treatment of acute and chronic neurologic insults.
    Lipton SA
    NeuroRx; 2004 Jan; 1(1):101-10. PubMed ID: 15717010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [HIV-1 neuropathogenesis: therapeutic strategies against neuronal loss induced by gp120/Tat glycoprotein in the central nervous system].
    Merino JJ; Montes ML; Blanco A; Bustos MJ; Oreja-Guevara C; Bayon C; Cuadrado A; Lubrini G; Cambron I; Munoz A; Cebolla S; Gutierrez-Fernandez M; Bernardino JI; Arribas JR; Fiala M
    Rev Neurol; 2011 Jan; 52(2):101-11. PubMed ID: 21271550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paradigm shift in NMDA receptor antagonist drug development: molecular mechanism of uncompetitive inhibition by memantine in the treatment of Alzheimer's disease and other neurologic disorders.
    Lipton SA
    J Alzheimers Dis; 2004 Dec; 6(6 Suppl):S61-74. PubMed ID: 15665416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential Effects of Pharmacologic and Genetic Modulation of NMDA Receptor Activity on HIV/gp120-Induced Neuronal Damage in an In Vivo Mouse Model.
    Nakanishi N; Kang YJ; Tu S; McKercher SR; Masliah E; Lipton SA
    J Mol Neurosci; 2016 Jan; 58(1):59-65. PubMed ID: 26374431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.